Modern Methods of Diagnosis and Treatment of Systemic Lupus Erythematosus

Azimova Mavlyuda Makhmudovna PhD, Associate Professor of department “Propaedeutics of Internal Diseases No. 2”, Tashkent State Medical University, Tashkent, Uzbekistan Irisbekov Behruz 3nd-year student, Faculty of General Medicine, Group 302B, Tashkent State Medical University, Tashkent, Uzbekistan

DSpace Home
→
Article and Thesis
→
Untitled
→
View Item

dc.contributor.author	Azimova Mavlyuda Makhmudovna PhD, Associate Professor of department “Propaedeutics of Internal Diseases No. 2”, Tashkent State Medical University, Tashkent, Uzbekistan Irisbekov Behruz 3nd-year student, Faculty of General Medicine, Group 302B, Tashkent State Medical University, Tashkent, Uzbekistan
dc.date.accessioned	2026-03-14T06:22:57Z
dc.date.available	2026-03-14T06:22:57Z
dc.date.issued	2026-02-28
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/3145
dc.description.abstract	Systemic lupus erythematosus (SLE) is a chronic autoimmune connective tissue disorder with multiorgan involvement, characterized by impaired immunologic tolerance, B-cell hyperactivation, and activation of the interferon cascade. Contemporary diagnostic approaches include expanded immunologic profiling, molecular genetic studies, and the use of biomarkers of organ damage. SLE treatment is currently shifting from nonspecific immunosuppression toward personalized targeted therapy. The introduction of biologic agents and the treat-to- target strategy has substantially improved disease prognosis.	en_US
dc.language.iso	en	en_US
dc.subject	ystemic lupus erythematosus, autoimmune disease, antinuclear antibodies, EULAR/ACR 2019 criteria, lupus nephritis, interferon signature, targeted therapy, biologic agents, treat-to-target, immunologic biomarkers.	en_US
dc.title	Modern Methods of Diagnosis and Treatment of Systemic Lupus Erythematosus	en_US
dc.title.alternative	American Journal Of Biomedical Science & Pharmaceutical Innovation	en_US
dc.type	Article	en_US